The funds will support the construction of a new manufacturing facility and make significant upgrades to Otsuka ICU Medical's existing manufacturing site in Austin, Texas.

Philips has expanded its ultrasound portfolio with the launch of the Alturion system, which features AI-powered workflows and is intended for high-volume clinical environments.

Resmed’s decision to sell MatrixCare to PE firm Frazier Healthcare Partners comes less than a decade after its $750m acquisition of the software business.

VB Spine has signed a definitive agreement with Augmedics to acquire the exclusive rights to the CT-Fluoro technology for spine applications.

The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for cataract patients.

Under the deal, Ottobock will inherit Fesia Technology’s portfolio of functional electrical stimulation (FES) products used in neurorehabilitation.

The company has since learned the cyberattack was caused by a third-party contractor’s user session within its cloud-based system being compromised.

Swiss spine surgery company Neo Medical has commercially launched the Neo Instant MIS Access platform in the US.

Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have experienced a stroke.

OrthAlign has completed the first clinical procedures using its Lantern ASC system, designed for the ASC setting.

Funds will support Materna’s completion of a pivotal trial evaluating its system for reducing pelvic floor muscle injury during childbirth, as well as other commercial activities.

The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.